NEW YORK, Aug. 7, 2019 /PRNewswire/ -- Disrupting the natural healthcare industry by injecting a fresh take on preventative care is the name of the game for Family Self Care's

SAINT PAUL, Minn., Aug. 7, 2019 /PRNewswire/ -- The American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College Health Association (ACHA), American College of Obstetricians and Gynecologists (ACOG), American Pharmacists Association (APhA), Immunization Action Coalition (IAC), and Society for Adolescent Hea

NILES, Ill., Aug. 7, 2019 /PRNewswire/ -- Building upon a legacy of creating high-quality, realistic baby dolls since 1985, Ashton-Drake introduces Kayla the Comfort Doll, a doll designed for those living with the effects of Alzheimer's and other forms of dementia. It is a special addition in the company's So Truly Real® Cuddling Comfort lin

Strainprint™ Technologies Ltd., Gynica & Lumir Lab to release custom questionnaire to select eligible participants for world-leading medical cannabis research TORONTO, Aug. 7, 2019 /PRNewswire/ -

EMERYVILLE, Calif., Aug. 7, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader in digital cell biology, today announced the appointment of

PHILADELPHIA, Aug. 7, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338 for adult onset Still's disease (AOSD),

CAMBRIDGE, Mass., Aug. 7, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for avapritinib for the treatment of adult patients

ISFIYA, Israel, Aug. 7, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only preparation-free ingestible capsule

KFAR SABA, Israel, Aug. 7, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the successful enrollment and operation of the first two patients in the Agili-C™ Investigational Device Exemption (IDE) pivotal study at Hospital for Special Surgery (HSS), New York, NY

FT. LAUDERDALE, Fla., Aug. 7, 2019 /PRNewswire/ -- According to a new study by Weatherby Healthcare, nearly two-thirds of actively practicing physicians are still carrying